RxAll™ is a digital infrastructure platform for healthcare. We enable on-demand access to high quality medicines at manufacturer/wholesale price to hospitals, pharmacies and patients from our curated network of high quality wholesalers and pharma companies. We solve $1.25T problem of access to affordable safe drugs. Our tech stack includes a proprietary instant drug testing platform- RxScanner™- that helps our sellers authenticate the medicines they sell. We also have the RxPOS™ that helps our sellers manage and sell inventory in store and online through our RxDelivered™ marketplace. Further, we have our embedded fintech RxPay™ that helps finance invoices for buyers on our platform ensuring availability and affordability of high quality medicines from our pharma company and wholesaler partners to our B2B2C customers. Our vision is to enable universal access to high quality medicines at the lowest prices to all humans across the world - starting with Africa.
Looking for a particular RxAll employee's phone or email?
The RxAll annual revenue was $6 million in 2026.
Amy Kao is the Co-Founder and President and Chief Marketing Officer of RxAll.
16 people are employed at RxAll.
RxAll is based in New Haven, Connecticut.
The NAICS codes for RxAll are [42421, 4242, 42, 424].
The SIC codes for RxAll are [51, 512].